NCT07359833

Brief Summary

One-lung ventilation (OLV) is routinely used during thoracic surgery to facilitate surgical exposure but is associated with an increased risk of intraoperative hypoxemia. To prevent hypoxia, high fractions of inspired oxygen (FiO₂) are commonly administered; however, excessive oxygen delivery may lead to hyperoxia and oxidative tissue injury. The Oxygen Reserve Index (ORi) is a novel, noninvasive monitoring parameter that provides real-time information on moderate hyperoxia and may allow more precise titration of FiO₂ during anesthesia. The aim of this prospective, randomized clinical trial is to evaluate whether ORi-guided intraoperative oxygen management can reduce oxygen exposure during OLV without increasing hypoxemia and to assess its effects on oxidative stress biomarkers and postoperative outcomes. Adult patients undergoing elective thoracic surgery with OLV are randomized to receive either ORi-guided FiO₂ titration or conventional oxygen management. Oxidative stress biomarkers and postoperative pulmonary complications are compared between groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 5, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2023

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

January 17, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 22, 2026

Completed
Last Updated

January 22, 2026

Status Verified

August 1, 2022

Enrollment Period

11 months

First QC Date

January 17, 2026

Last Update Submit

January 21, 2026

Conditions

Keywords

One-Lung Ventilationoxygen reserve indexHyperoxiaThoracic surgeryOxidative stressOxygen

Outcome Measures

Primary Outcomes (1)

  • Mean intraoperative FiO₂

    The primary outcome is the mean fraction of inspired oxygen (FiO₂) administered during one-lung ventilation and throughout the entire duration of surgery, recorded continuously intraoperatively and compared between the ORi-guided and conventional oxygen management groups.

    From anesthesia induction to the extubation

Secondary Outcomes (3)

  • Oxidative stress biomarkers (IL-6, SOD, MDA)

    Anesthesia induction, extubation, postoperative 12th hour, postoperative 24th hour

  • Postoperative pulmonary complications

    up to 2 weeks

  • Surgical site infections

    up to 2 weeks

Study Arms (2)

ORi group.

EXPERIMENTAL

In this group, intraoperative FiO₂ was titrated according to predefined Oxygen Reserve Index (ORi) thresholds during one-lung ventilation and all intraoperative period, with the aim of maintaining adequate oxygenation while avoiding unnecessary hyperoxia.

Device: Oxygen Reserve Index (ORi)-guided oxygen titration

Non-ORi group

NO INTERVENTION

In this group, intraoperative FiO₂ was adjusted based solely on pulse oximetry (SpO₂) monitoring, without the use of Oxygen Reserve Index (ORi) guidance.

Interventions

FiO₂ adjusted intraoperatively according to predefined ORi thresholds during thoracic surgery and one lung ventilation period.

ORi group.

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients age between 18-85 years Elective case Thoracic surgeries performed with one-lung ventilation using a double-lumen endotracheal tube Left ventricule ejection fraction(LVEF)\>45%

You may not qualify if:

  • heart failure (LVEF) \< 45% severe valvular disease admission as an emergency case history of prior lung resection presence of peripheral arterial disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University

Ankara, 06560, Turkey (Türkiye)

Location

Related Publications (1)

  • Saracoglu A, Yamansavci Sirzai E, Yildizeli B, Yuksel M, Aykac ZZ. Oxygen reserve index guided oxygen titration in one lung ventilation with low fresh gas flow. Turk J Med Sci. 2021 Oct 21;51(5):2413-2419. doi: 10.3906/sag-2009-149.

MeSH Terms

Conditions

Hyperoxia

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Buğra Aykenar

    Gazi University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A prospective, randomized, parallel-group clinical trial comparing ORi-guided intraoperative FiO₂ titration with conventional oxygen management in adult patients undergoing thoracic surgery with one-lung ventilation.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesia resident

Study Record Dates

First Submitted

January 17, 2026

First Posted

January 22, 2026

Study Start

August 5, 2022

Primary Completion

July 15, 2023

Study Completion

August 30, 2023

Last Updated

January 22, 2026

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

The data generated during this study may be made available for use in future meta-analyses upon reasonable request to the corresponding author.

Locations